Only 10 percent of hepatitis C sufferers in Japan who caught the cancer-causing virus from contaminated blood products might be eligible for compensation. This is because the source of infection for the others hasn’t been proven, a lawyer representing some of the victims said. Japan passed a law last week enabling victims to receive as much as 40 million yen (USD 377,000) in damages after transfusions they received more than a decade ago weren’t adequately treated and screened for diseases including HIV. (Bloomberg)

About the author

Join the Discussion